Onco-Path™ siRNA library

Avetra offers pre-designed siRNAs that target genes in known oncogenesis pathways. The siRNAs are chemically modified designed by our proprietary algorithm to minimize the risk of off-target effects and reduces cytokine induction. A minimum of 75% knock-down is guaranteed. Matching antibodies are available for protein expression studies.

Learn More »
image description

Custom Specialty Oligo Synthesis

Avetra specialized in siRNA, miRNA, shRNA, probes, beacons and all other highly modified oligos synthesis.

Contact Us »